-
Domestic CD19 car-t cell therapy! Casi / synbiotic cnct19 cell injection was approved by nmpa to carry out new drug clinical trials in China!
Time of Update: 2019-12-06
December 6, 2019 / BIOON / -- CASI pharmaceuticals, Inc is a NASDAQ listed Biomedical Company in the United States It has drug development, product acceleration and innovative therapy exploration plat
-
Esmd-2076, a CASI targeted drug, for the treatment of triple negative breast cancer
Time of Update: 2015-03-31
Casi pharmaceutical is committed to introducing, developing and commercializing innovative drugs, aiming at the tumor and other unmet medical needs, facing the global market and focusing on the Greate
-
Casi (yingchuangyuanda) company is transforming, focusing on Asia Pacific, and looking forward to becoming China's celgene
Time of Update: 2015-03-05
Source: Shannon Ellis 2015-03-05 Shanghai - CASI pharmaceuticals Inc., a NASDAQ listed company, is transforming into a new enterprise focusing on the Chinese tumor drug market based on its US foundati
-
Casi received the meeting minutes of FDA "guidance on clinical research and registration of enmd-2076 in the treatment of FLC"
Time of Update: 2015-02-12
Source: Biovalley 2015-02-12 Rockville, MD (February 11, 2015) - CASI pharmaceuticals, As a biopharmaceutical company, Inc (NASDAQ: CASI) is committed to the introduction, development and commercializ